Targeted Therapy of Respiratory Syncytial Virus in African Green Monkeys by Intranasally Administered 2-5A Antisense
- 1 January 2002
- Vol. 292 (1) , 70-77
- https://doi.org/10.1006/viro.2001.1213
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Controlling Gene Expression with 2-5A AntisenseMethods, 1999
- Discrimination between ribonuclease H- and ribonuclease L-mediated RNA degradation by 2′-O-methylated 2-5A-antisense oligonucleotidesBioorganic & Medicinal Chemistry Letters, 1999
- Targeting RNA decay with 2′,5′ oligoadenylate-antisense in respiratory syncytial virus-infected cellsProceedings of the National Academy of Sciences, 1997
- Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotidesAntiviral Research, 1997
- Relative Thermodynamic Stability of DNA, RNA, and DNA:RNA Hybrid Duplexes: Relationship with Base Composition and StructureBiochemistry, 1995
- Blockage of NF-κB Signaling by Selective Ablation of an mRNA target by 2-5A Antisense ChimerasScience, 1994
- Respiratory syncytial virus puzzle: Clinical features, pathophysiology, treatment, and preventionThe Journal of Pediatrics, 1992
- A semi-automated neutral red based chemosensitivity assay for drug screeningInvestigational New Drugs, 1990
- 2'-O-alkyl oligoribonucleotides as antisense probes.Proceedings of the National Academy of Sciences, 1990
- Synthesis and hybridization studies on two complementary nona(2'-O-methyl)ribonucleotidesNucleic Acids Research, 1987